User profiles for A. Morokoff
A/Prof Andrew MorokoffNeurosurgeon, University of Melbourne, Royal Melbourne Hospital Verified email at unimelb.edu.au Cited by 3714 |
The emergent role of exosomes in glioma
J Gourlay, AP Morokoff, RB Luwor, HJ Zhu… - Journal of Clinical …, 2017 - Elsevier
Extracellular vesicles (EVs) are known mediators of intercellular communication for both
normal and tumour cells. With the capability to transfer nucleic acids, proteins and lipids, EVs …
normal and tumour cells. With the capability to transfer nucleic acids, proteins and lipids, EVs …
[HTML][HTML] The role of interleukin‑6‑STAT3 signalling in glioblastoma
…, SS Stylli, H Nguyen, AP Morokoff… - Oncology …, 2018 - spandidos-publications.com
Glioblastoma is the most common type of malignant brain tumor among adults and is
currently a non‑curable disease due primarily to its highly invasive phenotype, and the lack of …
currently a non‑curable disease due primarily to its highly invasive phenotype, and the lack of …
[PDF][PDF] The role of spinal surgery in the treatment of low back pain
L Evans, T O'Donohoe, A Morokoff… - The Medical Journal of …, 2023 - mja.com.au
• Low back pain (LBP) is common and a leading cause of disability and lost productivity
worldwide. • Acute LBP is frequently self-resolving, but recurrence is common, and a significant …
worldwide. • Acute LBP is frequently self-resolving, but recurrence is common, and a significant …
[HTML][HTML] Motor neuroprosthesis implanted with neurointerventional surgery improves capacity for activities of daily living tasks in severe paralysis: first in-human …
…, V Hampshire, RP Sharma, A Morokoff… - Journal of …, 2021 - jnis.bmj.com
Background Implantable brain–computer interfaces (BCIs), functioning as motor neuroprostheses,
have the potential to restore voluntary motor impulses to control digital devices and …
have the potential to restore voluntary motor impulses to control digital devices and …
Prediction of seizure likelihood with a long-term, implanted seizure advisory system in patients with drug-resistant epilepsy: a first-in-man study
Background Seizure prediction would be clinically useful in patients with epilepsy and could
improve safety, increase independence, and allow acute treatment. We did a multicentre …
improve safety, increase independence, and allow acute treatment. We did a multicentre …
[HTML][HTML] Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity
…, S Amiridis, N Kountouri, W Ng, AP Morokoff… - PLoS …, 2017 - journals.plos.org
Glioblastoma (GBM) is a heterogeneous tumor of the brain with a poor prognosis due to
recurrence and drug resistance following therapy. Genome-wide profiling has revealed the …
recurrence and drug resistance following therapy. Genome-wide profiling has revealed the …
[HTML][HTML] VDAC2 enables BAX to mediate apoptosis and limit tumor development
…, S Chappaz, SL Khaw, C Chang, A Morokoff… - Nature …, 2018 - nature.com
Intrinsic apoptosis is critical to prevent tumor formation and is engaged by many anti-cancer
agents to eliminate tumor cells. BAX and BAK, the two essential mediators of apoptosis, are …
agents to eliminate tumor cells. BAX and BAK, the two essential mediators of apoptosis, are …
Surgery for convexity meningiomas
AP Morokoff, J Zauberman, PM Black - Neurosurgery, 2008 - journals.lww.com
OBJECTIVE: Meningiomas that occur over the convexity of the brain are the most common
meningiomas, but little has been published about their contemporary management. We …
meningiomas, but little has been published about their contemporary management. We …
[HTML][HTML] Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme
Accumulating evidence suggests that the stem cell markers CD133 and CD44 indicate molecular
subtype in Glioblastoma Multiforme (GBM). Gene coexpression analysis of The Cancer …
subtype in Glioblastoma Multiforme (GBM). Gene coexpression analysis of The Cancer …
IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low‐grade gliomas
Objective The isocitrate dehydrogenase 1 ( IDH 1) R132H mutation is the most common
mutation in World Health Organization ( WHO) grade II gliomas, reported to be expressed in 70–…
mutation in World Health Organization ( WHO) grade II gliomas, reported to be expressed in 70–…